BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31013164)

  • 21. Immune checkpoint inhibitor-related thyroid dysfunction.
    Iwama S; Kobayashi T; Yasuda Y; Arima H
    Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101660. PubMed ID: 35501263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
    Al Mushref M; Guido PA; Collichio FA; Moore DT; Clemmons DR
    Endocr Pract; 2020 Jan; 26(1):36-42. PubMed ID: 31461358
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
    Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between thyroid hormones and renal function in severe pre-eclampsia patients with hypothyroidism].
    Zhou J; Li W; Du J; Qiao C; Shang T; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Nov; 49(11):811-5. PubMed ID: 25603904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid Function in Newly Diagnosed HIV-positive Patients.
    Dutta SK; Kalita BC
    J Assoc Physicians India; 2023 May; 71(5):11-12. PubMed ID: 37355812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No Longterm Severe Thyroid Dysfunction Seen In Patients With Preexisting Reduced Serum Tt3 Concentrations After A Single Large Dose Of Iodinated Contrast.
    Hai-Long S; Qin Q; Yuan-Yuan L; Bing-Rang Z
    Endocr Pract; 2020 Aug; 26(8):840-845. PubMed ID: 33471675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Factors Associated with Thyroid Dysfunction: A Hospital Based Study.
    Risal P; Adhikari B; Shrestha R; Manandhar S; Bhatt RD; Hada M
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):88-92. PubMed ID: 32632053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin level and cognitive performance: Baseline results from the ELSA-Brasil Study.
    Szlejf C; Suemoto CK; Santos IS; Lotufo PA; Haueisen Sander Diniz MF; Barreto SM; Benseñor IM
    Psychoneuroendocrinology; 2018 Jan; 87():152-158. PubMed ID: 29096222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review.
    Floriani C; Feller M; Aubert CE; M'Rabet-Bensalah K; Collet TH; den Elzen WPJ; Bauer DC; Angelillo-Scherrer A; Aujesky D; Rodondi N
    Thyroid; 2018 May; 28(5):575-582. PubMed ID: 29631476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Spectrum of Thyroid Function Tests and Autoantibodies During Hospitalization and After Six Months of Discharge in COVID-19 Patients: Does COVID-19 Trigger Autoimmunity?
    Alphan Uc Z; Yagcı P; Adibelli Z; Duran C
    Endocr Res; 2023 Jul; 48(2-3):44-54. PubMed ID: 36883908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRON DEFICIENCY, A RISK FACTOR FOR THYROID AUTOIMMUNITY DURING SECOND TRIMESTER OF PREGNANCY IN CHINA.
    Zhang Y; Huang X; Chen Z; Yang Q; Li X; Zhang R; Yu Z; Li Q; Liu J; Zha B
    Endocr Pract; 2020 Jun; 26(6):595-603. PubMed ID: 31968188
    [No Abstract]   [Full Text] [Related]  

  • 34. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function.
    Tsai K; Ma H; Liang TZ; Xing Y; Chung S; Dorff T; Bell D; Lechner MG
    Thyroid; 2024 Feb; 34(2):158-166. PubMed ID: 38069567
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors.
    Yoon JH; Hong AR; Kim HK; Kang HC
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):413-423. PubMed ID: 33820396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Korean pediatric reference intervals for FT4, TSH, and TPO Ab and the prevalence of thyroid dysfunction: A population-based study.
    Lim HH
    Clin Biochem; 2017 Dec; 50(18):1256-1259. PubMed ID: 29024619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid Function in Patients with Cystic Fibrosis: No Longer a Concern?
    Lee SY; Chesdachai S; Lee MJ; He XM; Tangpricha V; Braverman LE
    Thyroid; 2016 Jul; 26(7):875-9. PubMed ID: 27114049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study.
    Yeap BB; Alfonso H; Hankey GJ; Flicker L; Golledge J; Norman PE; Chubb SA
    Eur J Endocrinol; 2013 Oct; 169(4):401-8. PubMed ID: 23853210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma.
    Morganstein DL; Lai Z; Spain L; Diem S; Levine D; Mace C; Gore M; Larkin J
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):614-620. PubMed ID: 28028828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.